Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Frank Neumann

Showing results (41-50 of 118) with videos related to

Pageof 12
Sort By:
Leukemia Research|January 31, 2006
Absence of the JAK2 mutation V617F in CD34+ hematopoietic stem and progenitor cells from patients with BCR-ABL-positive CML in chronic phase and blast crisisRalf Kronenwett, Thorsten Gräf, Frank Neumann, et al.
International Journal of Cancer|February 14, 2015
CD4⁺ T cells in chronic autoantigenic stimulation in MGUS, multiple myeloma and Waldenström's macroglobulinemiaFrank Neumann, Michael Pfreundschuh, Klaus D Preuss, et al.
Blood|July 21, 2005
Identification of an epitope derived from the cancer testis antigen HOM-TES-14/SCP1 and presented by dendritic cells to circulating CD4+ T cellsFrank Neumann, Claudia Wagner, Klaus-Dieter Preuss, et al.
Transplantation|September 28, 2004
Rapid identification of preformed alloreactive T cells for use in a clinical settingUrban Sester, Stephan Thijssen, Kai van Bentum, et al.
Cancer Immunology, Immunotherapy : CII|June 2, 2011
A peptide epitope derived from the cancer testis antigen HOM-MEL-40/SSX2 capable of inducing CD4⁺ and CD8⁺ T-cell as well as B-cell responsesFrank Neumann, Boris Kubuschok, Kubilay Ertan, et al.
Journal of Immunology (Baltimore, Md. : 1950)|September 30, 2015
MHC/Peptide-Specific Interaction of the Humoral Immune System: A New Category of AntibodiesGerhard Held, Immanuel F Luescher, Frank Neumann, et al.
Leukemia|June 29, 2018
A prospective study on serum Cytokeratin (CK)-18 and CK18 fragments as biomarkers of acute hepato-intestinal GVHDSandra Sauer, Johannes Hüsing, Jacek Hajda, et al.
Frontiers in Oncology|December 28, 2020
Role of Specific B-Cell Receptor Antigens in LymphomagenesisLorenz Thurner, Sylvia Hartmann, Frank Neumann, et al.
Leukemia Research|January 29, 2008
Unrelated umbilical cord blood transplantation as salvage treatment for engraftment failure following autologous stem cell transplantationRoland Fenk, Frank Neumann, Barbara Fenk, et al.
Immunology Letters|June 16, 2009
Fab antibodies capable of blocking T cells by competitive binding have the identical specificity but a higher affinity to the MHC-peptide-complex than the T cell receptorFrank Neumann, Christine Sturm, Martin Hülsmeyer, et al.
Pageof 12

Showing results (41-50 of 118) with videos related to

Sort By:
Pageof 12
Leukemia Research|January 31, 2006
Absence of the JAK2 mutation V617F in CD34+ hematopoietic stem and progenitor cells from patients with BCR-ABL-positive CML in chronic phase and blast crisisRalf Kronenwett, Thorsten Gräf, Frank Neumann, et al.
International Journal of Cancer|February 14, 2015
CD4⁺ T cells in chronic autoantigenic stimulation in MGUS, multiple myeloma and Waldenström's macroglobulinemiaFrank Neumann, Michael Pfreundschuh, Klaus D Preuss, et al.
Blood|July 21, 2005
Identification of an epitope derived from the cancer testis antigen HOM-TES-14/SCP1 and presented by dendritic cells to circulating CD4+ T cellsFrank Neumann, Claudia Wagner, Klaus-Dieter Preuss, et al.
Transplantation|September 28, 2004
Rapid identification of preformed alloreactive T cells for use in a clinical settingUrban Sester, Stephan Thijssen, Kai van Bentum, et al.
Cancer Immunology, Immunotherapy : CII|June 2, 2011
A peptide epitope derived from the cancer testis antigen HOM-MEL-40/SSX2 capable of inducing CD4⁺ and CD8⁺ T-cell as well as B-cell responsesFrank Neumann, Boris Kubuschok, Kubilay Ertan, et al.
Journal of Immunology (Baltimore, Md. : 1950)|September 30, 2015
MHC/Peptide-Specific Interaction of the Humoral Immune System: A New Category of AntibodiesGerhard Held, Immanuel F Luescher, Frank Neumann, et al.
Leukemia|June 29, 2018
A prospective study on serum Cytokeratin (CK)-18 and CK18 fragments as biomarkers of acute hepato-intestinal GVHDSandra Sauer, Johannes Hüsing, Jacek Hajda, et al.
Frontiers in Oncology|December 28, 2020
Role of Specific B-Cell Receptor Antigens in LymphomagenesisLorenz Thurner, Sylvia Hartmann, Frank Neumann, et al.
Leukemia Research|January 29, 2008
Unrelated umbilical cord blood transplantation as salvage treatment for engraftment failure following autologous stem cell transplantationRoland Fenk, Frank Neumann, Barbara Fenk, et al.
Immunology Letters|June 16, 2009
Fab antibodies capable of blocking T cells by competitive binding have the identical specificity but a higher affinity to the MHC-peptide-complex than the T cell receptorFrank Neumann, Christine Sturm, Martin Hülsmeyer, et al.
Pageof 12